Creation and Implementation of a BC/Canada Registry for Familial Hypercholesterolemia
Principal Investigator
Liam BrunhamOverview
Body Locations and Systems
Coronary Artery DiseaseDisorders and Conditions
GeneticsClinicalTrials.gov#
NCT02009345Status
RecruitingStudy Start/End
May 20, 2020 to Nov 30, 2020Name/Title
Tanya VasyukhnikEmail Address
tanya.vasyukhnik2@vch.caPurpose of Study
Familial hypercholesterolemia (FH) is the most frequent genetic lipoprotein disorder associated with premature coronary artery disease. The goal of this initiative is to create a registry of subjects with FH across Canada. The registry will help clinicians and researchers to determine the burden of disease and the long-term effects of treatment.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.